Exactly.

I work in this field. Doing phase 3 clinical trials costs between $5,000 to $20,000 per patient per year.

This particular drug did a phase 3 with 423 patients for 2 years, so you're looking at a cost of $4M to $16M just for this one trial alone. Then add on top all the CMC (manufacturing) research that needs to happen, the regulatory filing work, etc, etc.

Unless someone has a few hundreds of millions sitting around, you aren't bringing a novel drug to market without external funding.

When hospitals are contracted to do work in a clinical trial setting they take their costs and multiply it by 10 (at least). This was done in house with in house resources. This hospital has its own pharmacy that can synthesize drugs and give it to the patients. The pharmacy probably charged just the material costs internally and not for the time.